We next analyzed whether Fas-mediated cell death in the presence of Fas-GPI still occurred via apoptosis. Fas-GPI transfected or control Jurkat cells were mixed at a 1 : 1 ratio with WR19L or 1A12 ...

Apoptosis produced in B cells through Fas (APO-1, CD95) triggering is regulated by signals derived from other surface receptors: CD40 engagement produces upregulation of Fas expression and marked ...

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) ...

Apoptosis was quantified by fluorescein isothiocyanate-conjugated annexin V/flow cytometric analysis and by DNA fragmentation. Fas expression was measured by flow cytometric analysis.

Scientists have made a novel discovery about how gene, "Fas-apoptosis inhibitory molecule", protects both immune and liver cells from programmed cell death. Scientists at Singapore's Bioprocessing ...

CAR-T cells, which are genetically programmed to specifically recognize and kill target cells, have altered the therapeutic ...

A new study has discovered a promising approach to improve the efficacy of adoptive cell therapies for cancer. The research, published in Molecular Therapy: Nucleic Acids, describes the development of ...

Singapore scientists have made a novel discovery about how gene, "Fas-apoptosis inhibitory molecule," protects both immune and liver cells from programmed cell death. Their research is published ...

In support of this, cells carrying mutations in FasL, or its receptor Fas, were much less likely to undergo apoptosis when challenged with Aβ25-35. In addition, the researchers were able to show that ...

Introduction Substance P (SP) and its preferred receptor, the neurokinin-1 receptor (NK-1 R), are expressed in human tenocytes and this is particularly seen in the tenocytes in cases of tendinosis.

The influence of doxorubicin on apoptosis was studied by flow cytometry analysis. ... Doxorubicin Induces Fas-Mediated Apoptosis in Human Thyroid Carcinoma Cells - Medscape - Apr 01, 2004.

A new study has discovered a promising approach to improve the efficacy of adoptive cell therapies for cancer. The research, published in Molecular Therapy: Nucleic Acids, describes the development of ...